April 01, 2026
The U.S. Trustee's Office asked a New Jersey bankruptcy judge to convert drugmaker Nostrum Laboratories' Chapter 11 case to a Chapter 7 liquidation or dismiss it altogether because the debtor has not been filing monthly operating reports.
May 22, 2025
Bankrupt drugmaker Nostrum Laboratories received approval from a New Jersey court for a $1.75 million sale of an Ohio facility after reaching an agreement with the buyer and lenders over the costs of removing controlled substances at the property.
May 16, 2025
Waterford Bank NA has objected to New Jersey drugmaker Nostrum Laboratories Inc.'s plan to sell an Ohio property, saying the bank doesn't want to be left to pay for the disposal of large quantities of controlled substances left at the site, an issue the parties are now negotiating ahead of a hearing next week.
February 21, 2025
Citizens Bank, a creditor of New Jersey drugmaker Nostrum Laboratories Inc., objected to Nostrum's request to retain another investment banker in its Chapter 11 case, arguing that Raymond James is already serving in that role and that the additional $1 million in retention costs provides no "discernible benefit" to the debtor.
January 28, 2025
A bankruptcy judge on Tuesday approved a bid from the official committee of unsecured creditors in drugmaker Nostrum Laboratories Inc.'s Chapter 11 case to help investment bank Raymond James find a buyer for the debtor's assets.
January 22, 2025
The official committee of unsecured creditors in drugmaker Nostrum Laboratories Inc.'s Chapter 11 case has asked a New Jersey bankruptcy judge for additional authority to help investment bank Raymond James find a buyer for the debtor's assets.
January 17, 2025
Drugmaker Nostrum sought for more time to file a Chapter 11 plan, Swedish debt collection agency Intrum asked a Texas bankruptcy court to enforce its plan that a group of noteholders are opposing, and former employees of a bankrupt drink packager alleged they were unlawfully laid off without any advance warning.
December 03, 2024
Drugmaker Nostrum Laboratories told a New Jersey bankruptcy judge Tuesday that close to 30 parties are weighing bids for the company's assets, with the debtor planning to choose a stalking horse bidder in the coming weeks.
November 25, 2024
Drugmaker Nostrum Laboratories asked a New Jersey bankruptcy judge to extend its Chapter 11 automatic stay to its CEO and its parent company, Nostrum Pharmaceuticals LLC, both of which are nondebtors.
November 01, 2024
Rudy Giuliani was recently accused of ignoring subpoenas as two former election workers tried to collect on a $148 million defamation judgment, Steward Health Care creditors have opposed the formation of a tort claimants committee and Chinese exile Miles Guo's $26.5 million New Jersey mansion can be sold in Chapter 11.